In this episode of Posters to Practice: The Podcast, Joel L. Cohen, MD, a Dermatologist and the Director of AboutSkin Dermatology and DermSurgery in Greenwood Village and Lone Tree, CO, shares the results of a nine-month prospective study looking at the use of the new Nutrafol Men 50+ formulation among men with clinically confirmed hair thinning. He also discusses the active ingredients in the supplement, including Moldovian dragon head, marigold extract, Polyamine, tributyrin, and bamboo silica.

Among the key study findings:

• Fully 97% of men saw improved scalp quality
• 81% of men saw improved scalp coverage after nine months, the study showed.
• 90% of men reported slowed-down hair thinning
• 85% of men saw less shedding
• 84% of men saw thicker, fuller hair
• 87% of men saw improved hair growth
• 100% of men reported that their hair feels and looks healthier

This editorially independent podcast was supported by Nutrafol.

Growing numbers of people with atopic dermatitis (AD) are expressing ‘steroid phobia,’ and counseling these patients and their families on appropriate use of corticosteroids can help ease their concerns. There is a time and place for steroids in treating AD, but the advent of advanced non-steroidal topicals, including ruxolitinib (Opzelura, Incyte), a Janus kinase (JAK) inhibitor cream, is expanding treatment choices—without sacrificing efficacy.

In this episode of Prescribing Hope in AD: The Podcast, Raj Chovatiya, MD, PhD, MSCI, FAAD, an Associate Professor of Medicine at Rosalind Franklin University of Medicine and Science Chicago Medical School in North Chicago, IL, and Founder and Director of the Center for Medical Dermatology + Immunology Research in Chicago, IL, and Linda Stein Gold, MD, Director of Dermatology Clinical Research at Henry Ford Health in Detroit, MI, discuss the role of the new generation of advanced topicals in AD and compare and contrast potential side effects seen with steroids to the boxed warning that appears on topical JAK inhibitors, providing key context for treatment decision-making.

In this episode of Get Lit, Ted Rosen, MD, the Editor-in-Chief of The Dermatology Digest®, takes a deep dive into the recent dermatology literature, including a large-scale study in the April 2026 issue of Cancer Research Communications that showed that lifelong singles develop cancer at significantly higher rates than those who have or are married. He also weighs in on the possible unintended consequences of a price increase in condoms due to shipping disruptions in the Strait of Hormuz. “There's a concern in infectious disease circles that if condoms get too expensive, they won't be bought, they won't be used, and that there might be a surge in sexually transmitted diseases,” he says.